Ignite Creation Date:
2024-05-06 @ 3:16 PM
Last Modification Date:
2024-10-26 @ 1:46 PM
Study NCT ID:
NCT04577729
Status:
TERMINATED
Last Update Posted:
2023-07-10
First Post:
2020-09-30
Brief Title:
The IRMI-FMT Trial
Sponsor:
Medical University of Graz
Organization:
Medical University of Graz
Study Overview
Official Title:
INDUCING REMISSION IN MELANOMA PATIENTS WITH CHECKPOINT INHIBITOR THERAPY USING FECAL MICROBIOTA TRANSPLANTATION
Status:
TERMINATED
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Agreement with project partner prematurely cancelled
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Aim of the study is to investigate the effect of Fecal Microbiota Transplantation FMT and Checkpoint Inhibitor CI re-challenge in prior CI refractory patients on Progression free survival PFS and tumor using donor stool of former malignant melanoma patients who have been in remission due to CI treatment for at least 1 year
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None